13th Edition of International Conference on Neurology and Brain Disorders
October 19-21, 2026
Neurotoxicology
Neurotoxicology examines the harmful effects that toxic substances have on the nervous system, particularly how chemicals disrupt the brain's structure and function. Neurotoxins, which can be found in environmental pollutants, pharmaceuticals, and occupational settings, pose significant risks to both acute and chronic neurological health. Conditions such as peripheral neuropathy, cognitive decline, and movement disorders can result from exposure to these toxins. Understanding the pathways through which neurotoxins exert their effects—such as through oxidative stress, inflammation, and mitochondrial dysfunction—has become a critical area of research. Additionally, advances in toxicology are leading to improved risk assessments, better safety protocols, and therapeutic interventions that can mitigate the damage caused by neurotoxic substances.
Ken Ware
NeuroPhysics Therapy Institute and Research Centre, Australia
Yong Xiao Wang
Albany Medical College, United States
Joe Sam Robinson
Mercer University, United States
Daniel Curry
Texas Children’s Hospital, United States
Steven Benvenisti
Davis, Saperstein Salomon, PC, United States
Andrzej Stanislaw Cieplak
Independent researcher, United States
Younok Dumortier Shin
OnusBio, United StatesSubmit your abstract Today
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : ADNP regulates cortical development: Mechanism of ADNP syndrome/autism
Kazuhito Toyooka, Drexel University College of Medicine, United States
Title : Mild cognitive impairment (MCI) in Parkinson’s disease: Prevalence given MDS criteria
Cay Anderson Hanley, iPACES, United States
Title : Modeling early neurologic trajectories after elevated leg positioning (ELP): A secondary analysis of the LEG-UP randomized feasibility study
Kayode Ahmed, The University of Texas MD Anderson Cancer Center, United States
Title : Neuro-exergaming for non-verbal autism spectrum: A case study of neuropsychological function after 15 sessions of pedal-n-play iPACES
Cay Anderson Hanley, iPACES, United States
Title : Prescribing joy: The importance of integrating memory cafes into dementia care
Saul Beaumont, Massachusetts Advisory Council on Alzheimer's Disease and All Other Dementias, United States